Breaking News Instant updates and real-time market news.

07:25
05/05/20
05/05
07:25
05/05/20
07:25

FX Update. The dollar and yen have risen against most currencies

FX Update. The dollar and yen have risen against most currencies during the European morning, correcting some of the losses seen against the commodity currencies during the Asia-Pacific session. The two currencies, which broke the recent correlative pattern by rising despite a backdrop of buoyant global stock markets, were main benefactors of broad euro weakness. EUR-USD dropped to a six-day low at 1.0926, and EUR-JPY to 115.60, also a six-day nadir. This came after Germany's constitutional court gave the ECB three months to tweak the public sector purchase program and thus the central bank's extensive QE measures (ruling that some of the measures the Bundesbank is taking under the ECB's Public Sector Purchase Program are not covered by EU law). Elsewhere, the Canadian dollar and other oil-correlating currencies strengthened on the back of a rise crude prices. USD-CAD dropped below Monday's low in making a low at 1.4029, with the Canadian dollar advancing for the first time since last Wednesday. June WTI crude futures rose by over 10% in pegging a three-week high at $22.77. Goldman Sachs research raised its 2021 oil price forecast to $51. There is now a large body of analysts anticipating a rebound in oil prices, partly on the view that depleting storage capacity is forcing producers into sizeable output cuts. AUD-USD lifted above its Monday high in making a peak at 0.6462. The RBA left its cash rate unchanged at 0.25%, as had been widely anticipated, while loosening the minimum criteria for purchases of corporate debt under its QE program, which will now include debt rated to BBB-. Weekly jobs data out of Australian was down 7.5%. New Zealand reported no new coronavirus cases for a second day, reaffirming the success both New Zealand and Australian have had in containing the virus, which has prompted talk of a free travel policy between the two nations.

TODAY'S FREE FLY STORIES

Recommendations
Microsoft price target raised to $250 from $205 at Wells Fargo » 07:52
06/02/20
06/02
07:52
06/02/20
07:52
MSFT

Microsoft

$182.86 /

-0.38 (-0.21%)

, AMZN

Amazon.com

$2,474.16 /

+41 (+1.69%)

, GOOG

Alphabet

$1,431.91 /

+1.11 (+0.08%)

, GOOGL

Alphabet Class A

$1,435.12 /

-0.7 (-0.05%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$182.86 /

-0.38 (-0.21%)

AMZN Amazon.com
$2,474.16 /

+41 (+1.69%)

GOOG Alphabet
$1,431.91 /

+1.11 (+0.08%)

GOOGL Alphabet Class A
$1,435.12 /

-0.7 (-0.05%)

MSFT Microsoft
$182.86 /

-0.38 (-0.21%)

06:11 Today Cowen
Cowen starts Slack with Outperform given 'major booster shot' from COVID
05/28/20 Needham
Workday price target raised to $200 from $175 at Needham
05/27/20 Summit Insights
Microsoft initiated with a Buy at Summit Insights
05/18/20 RBC Capital
Microsoft price target raised to $200 from $196 at RBC Capital
AMZN Amazon.com
$2,474.16 /

+41 (+1.69%)

06/01/20 Morgan Stanley
Amazon.com price target raised to $2,800 from $2,600 at Morgan Stanley
05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/18/20 Bernstein
Amazon not building standalone overnight network, says Bernstein
05/14/20 KeyBanc
Farfetch, Nordstrom, Revolve could be impacted by Amazon offering, says KeyBanc
GOOG Alphabet
$1,431.91 /

+1.11 (+0.08%)

05/29/20 JPMorgan
Trump order may put 'overhang' on big tech in coming months, says JPMorgan
05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/12/20 Citi
Alphabet price target raised to $1,600 from $1,400 at Citi
05/07/20 Credit Suisse
YouTube TV deal 'the big news' from ViacomCBS report, says Credit Suisse
GOOGL Alphabet Class A
$1,435.12 /

-0.7 (-0.05%)

05/29/20 JPMorgan
Trump order may put 'overhang' on big tech in coming months, says JPMorgan
05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/12/20 Citi
Alphabet price target raised to $1,600 from $1,400 at Citi
05/07/20 Credit Suisse
YouTube TV deal 'the big news' from ViacomCBS report, says Credit Suisse
MSFT Microsoft
$182.86 /

-0.38 (-0.21%)

AMZN Amazon.com
$2,474.16 /

+41 (+1.69%)

GOOG Alphabet
$1,431.91 /

+1.11 (+0.08%)

GOOGL Alphabet Class A
$1,435.12 /

-0.7 (-0.05%)

MSFT Microsoft
$182.86 /

-0.38 (-0.21%)

AMZN Amazon.com
$2,474.16 /

+41 (+1.69%)

GOOG Alphabet
$1,431.91 /

+1.11 (+0.08%)

GOOGL Alphabet Class A
$1,435.12 /

-0.7 (-0.05%)

MSFT Microsoft
$182.86 /

-0.38 (-0.21%)

AMZN Amazon.com
$2,474.16 /

+41 (+1.69%)

GOOG Alphabet
$1,431.91 /

+1.11 (+0.08%)

GOOGL Alphabet Class A
$1,435.12 /

-0.7 (-0.05%)

MSFT Microsoft
$182.86 /

-0.38 (-0.21%)

AMZN Amazon.com
$2,474.16 /

+41 (+1.69%)

GOOG Alphabet
$1,431.91 /

+1.11 (+0.08%)

GOOGL Alphabet Class A
$1,435.12 /

-0.7 (-0.05%)

MSFT Microsoft
$182.86 /

-0.38 (-0.21%)

AMZN Amazon.com
$2,474.16 /

+41 (+1.69%)

GOOG Alphabet
$1,431.91 /

+1.11 (+0.08%)

GOOGL Alphabet Class A
$1,435.12 /

-0.7 (-0.05%)

Recommendations
Raytheon Technologies price target raised to $71 from $65 at Cowen » 07:48
06/02/20
06/02
07:48
06/02/20
07:48
RTX

Raytheon Technologies

$64.12 /

-0.48 (-0.74%)

Cowen analyst Cai von…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RTX Raytheon Technologies
$64.12 /

-0.48 (-0.74%)

RTX Raytheon Technologies
$64.12 /

-0.48 (-0.74%)

05/22/20 Jefferies
Jefferies adds six names to Franchise Picks list, including BioMarin and TJX
05/20/20 RBC Capital
RBC starts 'significantly undervalued' Raytheon Technologies at Outperform
05/20/20 RBC Capital
Raytheon Technologies initiated with an Outperform at RBC Capital
04/20/20 Credit Suisse
Raytheon Technologies price target lowered to $81 from $101.45 at Credit Suisse
RTX Raytheon Technologies
$64.12 /

-0.48 (-0.74%)

RTX Raytheon Technologies
$64.12 /

-0.48 (-0.74%)

RTX Raytheon Technologies
$64.12 /

-0.48 (-0.74%)

RTX Raytheon Technologies
$64.12 /

-0.48 (-0.74%)

Recommendations
Karuna Therapeutics price target raised to $126 from $117 at Wedbush » 07:48
06/02/20
06/02
07:48
06/02/20
07:48
KRTX

Karuna Therapeutics

$91.43 /

-2.83 (-3.00%)

Wedbush analyst Laura…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$91.43 /

-2.83 (-3.00%)

KRTX Karuna Therapeutics
$91.43 /

-2.83 (-3.00%)

06/01/20 Goldman Sachs
Karuna price target raised to $131 from $115 at Goldman Sachs
05/31/20 Stifel
Karuna schizophrenia drug has blockbuster potential, says Stifel
05/28/20 H.C. Wainwright
Karuna Therapeutics initiated with a Buy at H.C. Wainwright
05/08/20 Mizuho
Karuna Therapeutics price target raised to $116 from $103 at Mizuho
KRTX Karuna Therapeutics
$91.43 /

-2.83 (-3.00%)

KRTX Karuna Therapeutics
$91.43 /

-2.83 (-3.00%)

KRTX Karuna Therapeutics
$91.43 /

-2.83 (-3.00%)

Initiation
Ayala Pharmaceuticals initiated with a Hold at Jefferies » 07:47
06/02/20
06/02
07:47
06/02/20
07:47
AYLA

Ayala Pharmaceuticals

$15.30 /

+0.24 (+1.59%)

Jefferies analyst Maury…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AYLA Ayala Pharmaceuticals
$15.30 /

+0.24 (+1.59%)

07:41 Today Oppenheimer
Ayala Pharmaceuticals initiated with an Outperform at Oppenheimer
06:15 Today Citi
Ayala Pharmaceuticals initiated with a Buy at Citi
AYLA Ayala Pharmaceuticals
$15.30 /

+0.24 (+1.59%)

Conference/Events
American Renal Associates management to meet virtually with SunTrust » 07:47
06/02/20
06/02
07:47
06/02/20
07:47
ARA

American Renal Associates

$6.56 /

+0.42 (+6.84%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARA American Renal Associates
$6.56 /

+0.42 (+6.84%)

ARA American Renal Associates
$6.56 /

+0.42 (+6.84%)

09/10/19 SunTrust
American Renal Associates price target raised to $12 from $7 at SunTrust
Hot Stocks
360 Finance receives App Security, Information Security certifications » 07:47
06/02/20
06/02
07:47
06/02/20
07:47
QFIN

360 Finance

$9.50 /

-0.52 (-5.19%)

360 Finance announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QFIN 360 Finance
$9.50 /

-0.52 (-5.19%)

QFIN 360 Finance
$9.50 /

-0.52 (-5.19%)

04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Morgan Stanley
360 Finance initiated with an Overweight at Morgan Stanley
QFIN 360 Finance
$9.50 /

-0.52 (-5.19%)

QFIN 360 Finance
$9.50 /

-0.52 (-5.19%)

Hot Stocks
Tenax Therapeutics announces results from levosimendan study » 07:46
06/02/20
06/02
07:46
06/02/20
07:46
TENX

Tenax Therapeutics

$1.44 /

+ (+0.00%)

Tenax Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TENX Tenax Therapeutics
$1.44 /

+ (+0.00%)

Recommendations
Shoe Carnival to emerge as family footwear leader post crisis, says Susquehanna » 07:46
06/02/20
06/02
07:46
06/02/20
07:46
SCVL

Shoe Carnival

$26.00 /

+0.03 (+0.12%)

Susquehanna analyst Sam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SCVL Shoe Carnival
$26.00 /

+0.03 (+0.12%)

SCVL Shoe Carnival
$26.00 /

+0.03 (+0.12%)

05/21/20 Wedbush
Shoe Carnival price target raised to $32 from $25 at Wedbush
05/21/20 Susquehanna
Shoe Carnival price target raised to $31 from $23 at Susquehanna
03/26/20 Wedbush
Shoe Carnival price target lowered to $25 from $44 at Wedbush
03/19/20 Susquehanna
Shoe Carnival price target lowered to $18 from $47 at Susquehanna
SCVL Shoe Carnival
$26.00 /

+0.03 (+0.12%)

SCVL Shoe Carnival
$26.00 /

+0.03 (+0.12%)

SCVL Shoe Carnival
$26.00 /

+0.03 (+0.12%)

Hot Stocks
Realty Income reports 82.0% of contractual rent due for May » 07:46
06/02/20
06/02
07:46
06/02/20
07:46
O

Realty Income

$56.64 /

+1.375 (+2.49%)

Realty Income provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
O Realty Income
$56.64 /

+1.375 (+2.49%)

O Realty Income
$56.64 /

+1.375 (+2.49%)

05/04/20 Morgan Stanley
Morgan Stanley shakes up REIT ratings with Realty Income upgrade, two downgrades
05/04/20 Morgan Stanley
Realty Income upgraded to Overweight from Equal Weight at Morgan Stanley
04/24/20 Mizuho
Store Capital downgraded to Neutral from Buy at Mizuho
04/08/20 Odeon Capital
Realty Income initiated with a Buy at Odeon Capital
O Realty Income
$56.64 /

+1.375 (+2.49%)

O Realty Income
$56.64 /

+1.375 (+2.49%)

Recommendations
FirstCash removed from Best Ideas List at Wedbush » 07:46
06/02/20
06/02
07:46
06/02/20
07:46
FCFS

FirstCash

$69.01 /

-0.9 (-1.29%)

Wedbush removed FirstCash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FCFS FirstCash
$69.01 /

-0.9 (-1.29%)

FCFS FirstCash
$69.01 /

-0.9 (-1.29%)

04/02/20 Wedbush
FirstCash added to Best Ideas List at Wedbush
03/25/20 Janney Montgomery Scott
FirstCash upgraded to Buy from Neutral at Janney Montgomery Scott
03/24/20 Wedbush
FirstCash upgraded to Outperform from Neutral at Wedbush
10/24/19 JMP Securities
FirstCash downgraded to Market Perform from Outperform at JMP Securities
FCFS FirstCash
$69.01 /

-0.9 (-1.29%)

FCFS FirstCash
$69.01 /

-0.9 (-1.29%)

Recommendations
Evolent Health price target lowered to $13 from $17 at Canaccord » 07:46
06/02/20
06/02
07:46
06/02/20
07:46
EVH

Evolent Health

$6.84 /

-2.05 (-23.06%)

Canaccord analyst Richard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVH Evolent Health
$6.84 /

-2.05 (-23.06%)

EVH Evolent Health
$6.84 /

-2.05 (-23.06%)

07:27 Today Cantor Fitzgerald
Evolent Health downgraded to Neutral from Overweight at Cantor Fitzgerald
06/01/20 Cantor Fitzgerald
Evolent Health downgraded to Neutral from Overweight at Cantor Fitzgerald
06/01/20 Piper Sandler
Evolent Health core business is undervalued, says Piper Sandler
06/01/20 Cantor Fitzgerald
Evolent Health price target lowered to $9 from $14 at Cantor Fitzgerald
EVH Evolent Health
$6.84 /

-2.05 (-23.06%)

EVH Evolent Health
$6.84 /

-2.05 (-23.06%)

EVH Evolent Health
$6.84 /

-2.05 (-23.06%)

EVH Evolent Health
$6.84 /

-2.05 (-23.06%)

Downgrade
1-800-Flowers.com cut to Underperform at DA Davidson on impending recession » 07:45
06/02/20
06/02
07:45
06/02/20
07:45
FLWS

1-800-Flowers.com

$22.81 /

+0.64 (+2.89%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLWS 1-800-Flowers.com
$22.81 /

+0.64 (+2.89%)

FLWS 1-800-Flowers.com
$22.81 /

+0.64 (+2.89%)

06:36 Today DA Davidson
1-800-Flowers.com downgraded to Underperform from Neutral at DA Davidson
04/13/20 DA Davidson
1-800-Flowers.com downgraded to Neutral from Buy at DA Davidson
04/13/20 DA Davidson
1-800-Flowers.com downgraded to Neutral from Buy at DA Davidson
01/24/20 Northcoast
1-800-Flowers.com upgraded to Buy from Neutral at Northcoast
FLWS 1-800-Flowers.com
$22.81 /

+0.64 (+2.89%)

FLWS 1-800-Flowers.com
$22.81 /

+0.64 (+2.89%)

General news
Treasury Market Outlook: global equities are extending gains » 07:45
06/02/20
06/02
07:45
06/02/20
07:45

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Epizyme removed from Best Ideas List at Wedbush » 07:44
06/02/20
06/02
07:44
06/02/20
07:44
EPZM

Epizyme

$17.12 /

-0.5 (-2.84%)

Wedbush removed Epizyme…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EPZM Epizyme
$17.12 /

-0.5 (-2.84%)

EPZM Epizyme
$17.12 /

-0.5 (-2.84%)

04/01/20 Oppenheimer
Epizyme downgraded to Perform at Oppenheimer
04/01/20 Oppenheimer
Epizyme downgraded to Perform from Outperform at Oppenheimer
03/18/20 Wedbush
Epizyme added to Best List Ideas at Wedbush
03/04/20 Barclays
Barclays starts small, mid cap Biotechnology sector with Positive view
EPZM Epizyme
$17.12 /

-0.5 (-2.84%)

EPZM Epizyme
$17.12 /

-0.5 (-2.84%)

Conference/Events
Health Catalyst management to meet virtually with Cantor Fitzgerald » 07:44
06/02/20
06/02
07:44
06/02/20
07:44
HCAT

Health Catalyst

$26.80 /

-0.34 (-1.25%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HCAT Health Catalyst
$26.80 /

-0.34 (-1.25%)

HCAT Health Catalyst
$26.80 /

-0.34 (-1.25%)

05/27/20 Piper Sandler
Piper bullish on post pandemic opportunities for Health Catalyst
05/15/20
Fly Intel: Top five analyst initiations
05/15/20 Guggenheim
Guggenheim sees Health Catalyst at attractive entry point, starts at Buy
05/15/20 Guggenheim
Health Catalyst initiated with a Buy at Guggenheim
HCAT Health Catalyst
$26.80 /

-0.34 (-1.25%)

HCAT Health Catalyst
$26.80 /

-0.34 (-1.25%)

Initiation
Guggenheim starts Progyny at Buy, sees opportunity in pullback » 07:43
06/02/20
06/02
07:43
06/02/20
07:43
PGNY

Progyny

$23.92 /

-1.01 (-4.05%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PGNY Progyny
$23.92 /

-1.01 (-4.05%)

PGNY Progyny
$23.92 /

-1.01 (-4.05%)

06:10 Today Guggenheim
Progyny initiated with a Buy at Guggenheim
04/09/20 JPMorgan
Progyny should see 'very strong recovery' in 2021, says JPMorgan
11/19/19 JPMorgan
Progyny initiated with an Overweight at JPMorgan
11/19/19 Citi
Progyny initiated with a Buy at Citi
PGNY Progyny
$23.92 /

-1.01 (-4.05%)

PGNY Progyny
$23.92 /

-1.01 (-4.05%)

PGNY Progyny
$23.92 /

-1.01 (-4.05%)

Hot Stocks
Moleculin Biotech recruits first patient in Phase 1 clinical trial of WP1066 » 07:42
06/02/20
06/02
07:42
06/02/20
07:42
MBRX

Moleculin Biotech

$1.17 /

+0.075 (+6.85%)

Moleculin Biotech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MBRX Moleculin Biotech
$1.17 /

+0.075 (+6.85%)

MBRX Moleculin Biotech
$1.17 /

+0.075 (+6.85%)

04/08/20 Roth Capital
Moleculin can expedite COVID candidate amid less restrictions, says Roth Capital
10/17/19 Oppenheimer
Moleculin Biotech initiated with an Outperform at Oppenheimer
Hot Stocks
Moderna announces new research to be highlighted at Science Day » 07:41
06/02/20
06/02
07:41
06/02/20
07:41
MRNA

Moderna

$62.17 /

+0.72 (+1.17%)

Moderna announced new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$62.17 /

+0.72 (+1.17%)

MRNA Moderna
$62.17 /

+0.72 (+1.17%)

06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
05/20/20 Morgan Stanley
Moderna price target raised to $90 from $37 at Morgan Stanley
05/19/20 Piper Sandler
Piper trims Moderna target to $100 on capital raise dilution
MRNA Moderna
$62.17 /

+0.72 (+1.17%)

MRNA Moderna
$62.17 /

+0.72 (+1.17%)

MRNA Moderna
$62.17 /

+0.72 (+1.17%)

MRNA Moderna
$62.17 /

+0.72 (+1.17%)

Initiation
Ayala Pharmaceuticals initiated with an Outperform at Oppenheimer » 07:41
06/02/20
06/02
07:41
06/02/20
07:41
AYLA

Ayala Pharmaceuticals

$15.30 /

+0.24 (+1.59%)

, BMY

Bristol-Myers

$60.31 /

+0.59 (+0.99%)

Oppenheimer analyst Jay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$60.31 /

+0.59 (+0.99%)

AYLA Ayala Pharmaceuticals
$15.30 /

+0.24 (+1.59%)

06:15 Today Citi
Ayala Pharmaceuticals initiated with a Buy at Citi
BMY Bristol-Myers
$60.31 /

+0.59 (+0.99%)

05/13/20 Stifel
Bluebird's ide-cel remains approvable despite FDA's 'strict stance,' says Stifel
05/13/20 Piper Sandler
Bluebird should be able to easily address RTF issues, says Piper Sandler
05/12/20 Oppenheimer
Bluebird Bio price target lowered to $111 from $122 at Oppenheimer
04/20/20 Piper Sandler
Exelixis combo approval would increase kidney cancer use, says Piper Sandler
BMY Bristol-Myers
$60.31 /

+0.59 (+0.99%)

BMY Bristol-Myers
$60.31 /

+0.59 (+0.99%)

AYLA Ayala Pharmaceuticals
$15.30 /

+0.24 (+1.59%)

BMY Bristol-Myers
$60.31 /

+0.59 (+0.99%)

BMY Bristol-Myers
$60.31 /

+0.59 (+0.99%)

Recommendations
MongoDB price target raised to $275 from $130 at Barclays » 07:41
06/02/20
06/02
07:41
06/02/20
07:41
MDB

MongoDB

$238.36 /

+5.67 (+2.44%)

Barclays analyst Raimo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDB MongoDB
$238.36 /

+5.67 (+2.44%)

MDB MongoDB
$238.36 /

+5.67 (+2.44%)

05/22/20 Stifel
MongoDB price target raised to $225 from $160 at Stifel
04/19/20 Stifel
MongoDB price target raised to $160 from $135 at Stifel
03/18/20 Oppenheimer
MongoDB price target lowered to $140 from $155 at Oppenheimer
03/18/20 DA Davidson
MongoDB price target lowered to $105 from $143 at DA Davidson
MDB MongoDB
$238.36 /

+5.67 (+2.44%)

MDB MongoDB
$238.36 /

+5.67 (+2.44%)

MDB MongoDB
$238.36 /

+5.67 (+2.44%)

Hot Stocks
Dick's Sporting has re-opened approximately 80% of its stores as of 5/30  07:40
06/02/20
06/02
07:40
06/02/20
07:40
DKS

Dick's Sporting

$36.47 /

+0.37 (+1.02%)

 
ShowHide Related Items >><<
DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

05/28/20 Wedbush
Dick's Sporting price target raised to $33 from $22 at Wedbush
05/11/20 Nomura Instinet
Dick's Sporting price target raised to $33 from $28 at Nomura Instinet
04/28/20 Barclays
Dick's Sporting price target lowered to $35 from $42 at Barclays
03/25/20
Dick's Sporting management to meet with Susquehanna
DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

Hot Stocks
VIVUS announces updated agreement with Icahn Enterprises » 07:40
06/02/20
06/02
07:40
06/02/20
07:40
VVUS

VIVUS

$1.12 /

-0.01 (-0.88%)

, IEP

Icahn Enterprises

$49.11 /

-0.76 (-1.52%)

VIVUS (VVUS) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VVUS VIVUS
$1.12 /

-0.01 (-0.88%)

IEP Icahn Enterprises
$49.11 /

-0.76 (-1.52%)

VVUS VIVUS
$1.12 /

-0.01 (-0.88%)

03/04/20 Wells Fargo
VIVUS price target lowered to $1.75 from $10 at Wells Fargo
IEP Icahn Enterprises
$49.11 /

-0.76 (-1.52%)

VVUS VIVUS
$1.12 /

-0.01 (-0.88%)

IEP Icahn Enterprises
$49.11 /

-0.76 (-1.52%)

VVUS VIVUS
$1.12 /

-0.01 (-0.88%)

Hot Stocks
Dick's Sporting CEO says company 'in a position of strength' » 07:39
06/02/20
06/02
07:39
06/02/20
07:39
DKS

Dick's Sporting

$36.47 /

+0.37 (+1.02%)

"Although the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

05/28/20 Wedbush
Dick's Sporting price target raised to $33 from $22 at Wedbush
05/11/20 Nomura Instinet
Dick's Sporting price target raised to $33 from $28 at Nomura Instinet
04/28/20 Barclays
Dick's Sporting price target lowered to $35 from $42 at Barclays
03/25/20
Dick's Sporting management to meet with Susquehanna
DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

DKS Dick's Sporting
$36.47 /

+0.37 (+1.02%)

Recommendations
Broadcom price target raised to $340 from $300 at Susquehanna » 07:39
06/02/20
06/02
07:39
06/02/20
07:39
AVGO

Broadcom

$289.72 /

-2.12 (-0.73%)

Susquehanna analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVGO Broadcom
$289.72 /

-2.12 (-0.73%)

AVGO Broadcom
$289.72 /

-2.12 (-0.73%)

05/08/20 DA Davidson
SailPoint price target raised to $24 from $18 at DA Davidson
05/04/20 KeyBanc
Apple cautious iPhone outlook likely a headwind for chip suppliers, says KeyBanc
05/01/20 BTIG
Crowdstrike price target raised to $80 from $67 at BTIG
04/09/20 KeyBanc
KeyBanc remains cautious on Apple supply chain stocks, only recommends Broadcom
AVGO Broadcom
$289.72 /

-2.12 (-0.73%)

AVGO Broadcom
$289.72 /

-2.12 (-0.73%)

AVGO Broadcom
$289.72 /

-2.12 (-0.73%)

AVGO Broadcom
$289.72 /

-2.12 (-0.73%)

Hot Stocks
Uniti Group completes sale of U.S. tower business for $220M » 07:38
06/02/20
06/02
07:38
06/02/20
07:38
UNIT

Uniti Group

$8.74 /

+0.49 (+5.94%)

Uniti Group announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UNIT Uniti Group
$8.74 /

+0.49 (+5.94%)

UNIT Uniti Group
$8.74 /

+0.49 (+5.94%)

05/12/20 Raymond James
Uniti Group upgraded to Strong Buy from Outperform at Raymond James
05/12/20 Raymond James
Uniti Group upgraded to Strong Buy from Outperform at Raymond James
03/03/20 Raymond James
Uniti Group upgraded to Outperform from Market Perform at Raymond James
03/02/20 Raymond James
Uniti Group upgraded to Outperform from Market Perform at Raymond James
UNIT Uniti Group
$8.74 /

+0.49 (+5.94%)

UNIT Uniti Group
$8.74 /

+0.49 (+5.94%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.